Synlogic and Caldera Therapeutics have signed a definitive merger agreement aimed at combining in an all-stock transaction.The post Synlogic and...
Abbott has begun the TREAT TR study, to assess the safety and performance of its TriClip TEER system for patients...
Atea Pharmaceuticals has reported top line results from its Phase III C-BEYOND trial in North America, assessing the once-daily fixed-dose...
Eisai has entered an exclusive global licensing agreement with CORE Biomedicine for several preclinical oncology programmes.The post Eisai and CORE...
argenx has entered into a definitive agreement to acquire Forte Biosciences for approximately $2.2bn in total equity value.The post argenx...
Labcorp has launched Marker by Labcorp Genetic Health Panel, a test aimed at expanding consumer access to information about hereditary...
AstraZeneca has released findings from two Phase III studies, reporting outcomes for Ultomiris in thrombotic microangiopathy following HSCT-TMA and Sone-Ve...
EndoQuest Robotics has concluded subject enrolment in the PARADIGM trial, assessing the Endoluminal Surgical (ELS) System.The post Enrolment concludes in...
Estrella Immunopharma has dosed the first patient in the dose-expansion segment of its STARLIGHT-1 Phase I/II trial, assessing EB103 for...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.